REVENUE INTEREST FINANCING AGREEMENT among ALLURION TECHNOLOGIES, LLC and RTW MASTER FUND, LTD., RTW INNOVATION MASTER FUND, LTD., and RTW BIOTECH OPPORTUNITIES OPERATING LTD Dated as of October 30, 2024Revenue Interest Financing Agreement • November 4th, 2024 • Allurion Technologies, Inc. • Surgical & medical instruments & apparatus • New York
This Revenue Interest Financing Agreement (this “Agreement”) dated as of October 30, 2024 (the “Closing Date”) is among Allurion Technologies, LLC, a Delaware limited liability company (the “Company”), and RTW Master Fund, Ltd., an exempted company incorporated in the Cayman Islands with limited liability, RTW Innovation Master Fund, Ltd., an exempted company incorporated in the Cayman Islands with limited liability, and RTW Biotech Opportunities Operating Ltd, an investment company limited by shares incorporated under the laws of Guernsey (each and collectively, the “Investor”). Each of the Company and the Investor is referred to in this Agreement as a “Party” and collectively as the “Parties”.
